glycosyl
biolog
import
protein
modif
process
carbohydr
chain
enzymat
ad
protein
specif
amino
acid
residu
process
play
role
mani
cellular
function
includ
intracellular
traffick
cellcel
signal
protein
fold
receptor
bind
glycosyl
common
host
cell
process
util
mani
pathogen
well
protein
glycosyl
wide
employ
virus
host
invas
evas
host
immun
respons
thu
better
understand
viral
glycosyl
function
potenti
applic
improv
antivir
therapeut
vaccin
develop
summar
current
knowledg
broad
biolog
function
glycan
mononegaviral
order
envelop
negativesens
singlestrand
rna
virus
high
medic
import
includ
ebola
rabi
measl
nipah
virus
discuss
glycobiolog
find
genera
alphabet
order
within
eight
mononegaviral
famili
name
bornavirus
filovirus
mymonavirus
nyamivirus
paramyxovirus
pneumovirus
rhabdovirus
sunvirus
glycosyl
common
cellular
protein
modif
process
wherebi
carbohydr
glycan
attach
specif
amino
acid
side
chain
protein
result
glycoprotein
gp
cellular
glycan
function
includ
protein
traffick
fold
cellular
differenti
receptor
bind
cellcel
interact
cell
signal
addit
glycosyl
util
mani
pathogen
host
cell
invas
immun
system
evas
vigerust
shepherd
mani
virus
reli
specif
host
cell
glycosyl
pattern
bind
cell
andor
viral
entri
well
document
influenza
viru
human
immunodefici
viru
hiv
nizet
esko
virus
relianc
hijack
host
cell
machineri
reproduct
need
also
use
host
cell
machineri
glycosyl
gp
viral
encod
cellexecut
gp
ad
benefit
like
recogn
self
protein
host
immun
system
thu
help
hide
viru
host
defens
scanlan
et
al
hell
et
al
bier
et
al
viral
gp
contribut
multipl
viral
function
includ
viral
entri
immun
evas
merri
astrautsova
well
character
virus
hiv
glycosyl
protect
viru
antibodi
neutral
ogert
et
al
wei
et
al
scanlan
et
al
li
et
al
influenza
viru
glycosyl
modul
virul
immun
system
target
ohuchi
et
al
wagner
et
al
read
et
al
tate
job
et
al
vigerust
shepherd
function
glycosyl
viral
system
howev
remain
rel
less
character
two
main
protein
glycan
modif
type
util
virus
first
type
nlink
glycosyl
occur
nacetylglucosamin
glcnac
sugar
coval
attach
asparagin
n
residu
within
predict
sequenc
nxst
n
asparagin
x
amino
acid
prolin
st
serin
threonin
residu
nxst
motif
necessari
suffici
glycosyl
ectodomain
nxst
site
nglycosyl
factor
stabl
conform
adopt
local
protein
nxst
site
access
solvent
like
play
role
determin
whether
site
nglycosyl
baus
zielinska
et
al
nglycan
attach
protein
endoplasm
reticulum
er
earli
protein
synthesi
process
glycosyltransferas
transfer
highmannos
carbohydr
core
onto
protein
modif
occur
gp
progress
er
golgi
apparatu
addit
carbohydr
residu
ad
trim
nglycan
process
golgi
apparatu
identifi
highmannos
hybrid
complex
depend
carbohydr
content
branch
nizet
esko
aebi
figur
second
type
glycosyl
olink
glycosyl
occur
residu
though
residu
glycosyl
thu
oglycosyl
site
rel
difficult
predict
nglycosyl
site
oglycan
nacetylgalactosamin
galnac
sugar
link
olinkag
henc
structur
term
oglycan
free
hydroxyl
group
residu
brockhausen
et
al
addit
sugar
ad
numer
glycosyltransferas
result
format
differ
core
structur
modifi
rini
et
al
four
common
core
structur
shown
figur
oglycosyl
occur
posttransl
golgi
apparatu
unlik
nglycosyl
sugar
residu
ad
one
one
instead
block
figur
result
oglycan
tend
smaller
less
branch
nglycan
van
den
steen
et
al
lodish
et
al
peterkatalin
strategi
studi
glycosyl
advantag
disadvantag
exampl
mass
spectrometri
yield
valuabl
chemic
inform
often
requir
quantiti
protein
may
impract
viral
studi
rawl
melero
cell
treat
enzym
inhibitor
tunicamycin
chemic
inhibit
nglycan
synthesi
within
er
chemic
treatment
howev
addit
block
glycosyl
tunicamycin
may
undesir
side
effect
within
cell
protein
misfold
also
enzym
avail
studi
glycan
composit
peptidenglycosidas
f
pngase
f
cleav
nglycan
protein
endoglycosidas
h
endo
h
cleav
highmannos
oligosaccharid
hybrid
nglycosyl
site
complex
nglycan
endoglycosidas
f
endo
f
cleav
complex
glycan
leav
highmannos
glycan
intact
maley
et
al
addit
oglycosidas
remov
oglycan
brockhausen
et
al
magnelli
et
al
protein
lectin
addit
tool
specif
bind
certain
type
glycan
antibodi
specif
carbohydr
rawl
melero
strategi
involv
mutat
nxst
sequenc
via
sitedirect
mutagenesi
usual
mutat
n
conserv
q
glutamin
though
mutat
n
serin
n
alanin
st
g
glycin
publish
well
hu
et
al
zimmer
et
al
moll
et
al
schowalt
et
al
aguilar
et
al
addit
strategi
use
glycosylationdefect
cell
line
studi
glycan
effect
virus
viral
gp
lack
glycan
use
varieti
studi
result
compar
obtain
use
fulli
glycosyl
viru
viral
gp
noteworthi
differ
cell
type
differ
set
glycosyl
deglycosyl
enzym
thu
introduc
anoth
level
variabl
studi
glycan
function
mononegaviral
order
compris
negativesens
singlestrand
rna
virus
order
current
contain
eight
viral
famili
encompass
genera
known
speci
famili
follow
bornavirida
eg
borna
diseas
viru
filovirida
eg
ebola
marburg
virus
mymonavirida
eg
sclerotimonaviru
nyamivirida
eg
nyaviru
paramyxovirida
eg
measl
mump
nipah
virus
pneumovirida
eg
human
respiratori
syncyti
viru
human
metapneumoviru
rhabdovirida
eg
rabi
viru
sunvirida
eg
sunshineviru
amarasingh
et
al
figur
though
virus
vastli
differ
host
tissu
tropism
share
similar
genom
organ
consist
end
core
protein
gene
envelop
gp
gene
rnadepend
rna
polymeras
gene
kuhn
et
al
pfaller
et
al
evid
mononegaviral
virion
enclos
host
cellderiv
membran
envelop
kuhn
et
al
summar
known
function
nand
olink
glycan
mononegaviral
discuss
frequent
underestim
import
lipkin
et
al
although
pathogen
human
controversi
possibl
link
depress
schizophrenia
multipl
sclerosi
chronic
fatigu
syndrom
aggress
brain
tumor
suggest
ludwig
bode
ikuta
et
al
lipkin
et
al
tunicamycin
treatment
inhibit
product
infecti
bdv
glycosidas
treatment
elimin
viru
infect
suggest
glycan
play
signific
role
bdv
pathogen
stoyloff
et
al
two
report
glycosyl
bdv
protein
first
initi
suggest
integr
membran
matrixlik
gp
hatalski
et
al
stoyloff
et
al
later
propos
nonglycosyl
line
inner
leaflet
lipid
bilay
typic
cytoplasm
matrix
protein
mononegaviral
krau
et
al
suggest
essenti
infect
includ
epitop
import
viru
neutral
klich
et
al
hatalski
et
al
stoyloff
et
al
lectinbind
endoglycosidas
digest
assay
shown
matrix
protein
nbut
oglycosyl
klich
et
al
specif
effect
nglycan
bdv
infect
potenti
neutral
howev
still
unknown
second
glycosyl
protein
bdv
g
gp
thought
role
receptor
bind
viral
entri
bdv
g
shown
contain
nglycan
oglycan
specif
function
nglycan
remain
unknown
gonzalezdunia
et
al
schneider
et
al
filoviru
famili
compris
ebolaviru
marburgviru
cuevaviru
genera
ebolaviru
marburgviru
infect
caus
sever
hemorrhag
fever
mortal
rate
feldmann
geisbert
marcinkiewicz
et
al
zawilinska
koszvnenchak
virus
classifi
biosafeti
level
pathogen
due
high
mortal
rate
scarciti
approv
treatment
cure
recent
ebola
outbreak
africa
infect
individu
death
highlight
need
studi
deadli
virus
zeitlin
et
al
filovirus
reli
singl
gp
bind
host
cell
viralcel
membran
fusion
lead
viral
entri
white
et
al
hunt
et
al
gp
cleav
cathepsin
b
l
two
subunit
link
disulfid
bond
gp
bind
host
cell
gp
execut
membran
fusion
chandran
et
al
schornberg
et
al
kaletski
et
al
white
et
al
also
solubl
small
form
gp
sgp
whose
function
still
larg
unknown
suspect
act
immun
evas
decoy
antibodi
bind
ritchi
et
al
zawilinska
koszvnenchak
ebola
viru
ebov
gp
four
domain
base
receptorbind
domain
glycan
cap
domain
consist
nlink
glycan
site
mucinlik
domain
mld
heavili
oglycosyl
though
contain
nglycan
well
feldmann
et
al
feldmann
et
al
lee
et
al
powlesland
et
al
lennemann
et
al
davey
et
al
suggest
thick
glycan
layer
creat
around
gp
glycan
cap
mld
help
antibodi
evas
lee
et
al
support
hypothesi
mutat
two
nglycosyl
site
increas
immunogen
possibl
unmask
epitop
normal
cover
glycan
dowl
et
al
remark
nglycosyl
site
gp
success
mutat
concurr
without
affect
gp
express
lennemann
et
al
nglycan
remov
howev
increas
proteas
sensit
antibodi
sensit
transduct
pseudotyp
virion
cell
suggest
nglycan
protect
proteas
shield
antibodi
immun
respons
expens
viral
entri
effici
lennemann
et
al
singl
nglycosyl
site
mutat
asparagin
aspart
n
howev
found
similar
process
express
transduct
level
wildtyp
viru
jeffer
et
al
one
mutant
display
less
process
transduct
loss
nglycan
via
mutat
howev
result
alter
phenotyp
suggest
effect
observ
mutant
like
due
chang
protein
conform
site
near
cystein
residu
due
loss
nglycan
jeffer
et
al
addit
ideal
substitut
sinc
introduc
neg
charg
addit
loss
nglycan
separ
studi
howev
found
mutant
cathepsin
b
resist
suggest
glycan
import
gp
cleavag
process
wong
et
al
addit
amount
nglycan
process
also
determin
receptor
gp
bind
highmannos
nglycan
allow
dcsign
lectin
bind
lin
et
al
marzi
et
al
powlesland
et
al
lectin
lsectin
recogn
highmannos
glycan
form
gramberg
et
al
shown
bind
truncat
nglycan
powlesland
et
al
thu
nglycan
clearli
play
role
receptor
bind
proper
gp
cleavag
function
may
may
direct
role
viral
entri
modul
receptorinduc
membran
fusion
comparison
nglycan
remov
delet
oglycanrich
mld
promin
effect
delet
entir
mld
result
increas
process
incorpor
viral
entri
use
retrovir
system
express
ebov
gp
delet
oglycanrich
region
also
decreas
cellular
detach
capabl
abolish
cytopath
effect
vitro
vivo
reduc
immun
respons
mice
yang
et
al
jeffer
et
al
simmon
et
al
dowl
et
al
howev
sinc
mld
region
amino
acid
length
possibl
delet
region
affect
gp
conform
tran
et
al
viruslik
particl
vlp
studi
immun
mice
vlp
express
fulllength
gp
elicit
higher
antivir
titer
immun
vlp
express
mlddelet
gp
addit
epitop
protect
monoclon
antibodi
mab
map
domain
ctermin
gp
oglycanrich
region
wilson
et
al
use
two
differ
model
retrovir
system
vlp
highli
suggest
mld
import
immun
respons
least
mice
addit
play
role
viral
infect
note
mani
studi
delet
entir
oglycan
region
thu
remain
unclear
loss
oglycan
andor
loss
amino
acid
backbon
caus
observ
effect
addit
nglycan
within
mld
may
partial
contribut
phenotyp
observ
gp
subunit
contain
two
nglycosyl
site
conserv
among
five
ebov
speci
jeffer
et
al
ritchi
et
al
delet
one
two
nglycosyl
site
decreas
immunogen
mice
possibl
disrupt
dimer
gp
gp
dowl
et
al
interestingli
sgp
use
five
six
potenti
nglycosyl
site
contain
oglycan
falzarano
et
al
ritchi
et
al
sgp
nglycan
process
contain
complex
carbohydr
gp
reason
differ
process
still
undetermin
lennemann
et
al
ritchi
et
al
sinc
sgp
suspect
act
immun
system
decoy
would
interest
investig
whether
sgp
nglycan
play
immun
role
marburg
viru
contain
similar
number
nand
oglycan
ebov
sanchez
et
al
mani
nglycan
ebov
complex
marburg
viru
contain
mainli
highmannos
hybrid
nglycan
lack
termin
sialic
acid
feldmann
et
al
geyer
et
al
reason
effect
differ
among
filovirus
howev
yet
elucid
differ
may
consequ
differ
cell
line
use
studi
differ
virus
lloviu
viru
llov
first
discov
member
new
cuevaviru
genu
llov
isol
cueva
de
lloviu
asturia
spain
major
dieoff
schreiber
bat
negredo
et
al
similarli
ebola
marburg
virus
lloviu
requir
endosom
membran
protein
niemannpick
diseas
type
use
transport
cholesterol
cellular
membran
mediat
viral
entri
ng
et
al
wang
et
al
vesicular
stomat
viru
vsv
pseudotyp
virion
bear
llov
gp
vsvllov
yield
transduct
effici
compar
ebola
marburg
virus
ng
et
al
hoffmann
et
al
sequenc
analysi
llov
gp
show
contain
nglycan
nterminu
gp
cterminu
gp
treatment
pngase
f
also
suggest
llov
gp
contain
high
number
nglycan
similar
ebola
marburg
virus
howev
function
glycan
unknown
ng
et
al
ebola
marburg
virus
heavili
glycosyl
nand
oglycan
suggest
extrem
import
secondari
modif
less
research
done
marburg
viru
llov
difficult
determin
function
glycan
demonstr
ebov
conserv
among
filovirida
interest
note
ebov
nglycan
appear
play
import
role
cell
surfac
express
cse
differ
mononegavirus
mani
paramyxovirus
howev
filoviru
nglycan
seem
modul
proteas
sensit
thu
protein
process
appear
oglycanrich
region
involv
heavili
mani
function
sinc
studi
far
delet
entir
region
remain
determin
whether
oglycan
respons
phenotyp
observ
sclerotinia
sclerotiorum
negativestrand
rna
viru
known
member
sclerotimonaviru
genu
isol
china
fungal
plant
pathogen
sclerotinia
sclerotiorum
filament
viral
particl
shape
importantli
knowledg
first
fungusinfect
mononegaviru
discov
open
read
frame
analyz
six
protein
determin
multipl
potenti
nglycosyl
site
unknown
use
liu
et
al
famili
three
genera
nyaviru
socyviru
peropuviru
knowledg
glycan
identif
function
studi
done
member
nyamivirida
famili
genu
current
compris
nyamanini
viru
nymv
midway
viru
midwv
sierra
nevada
viru
snvv
pfaller
et
al
nymv
midwv
virus
tickborn
known
caus
diseas
human
anim
howev
infect
bird
kuhn
et
al
snvv
isol
outbreak
epizoot
bovin
abort
transmit
ornithodoro
coriaceu
tick
northern
california
roger
et
al
put
glycosyl
site
snvv
describ
nymv
midwv
predict
multipl
glycosyl
site
orf
v
nymv
one
put
olink
eight
potenti
nlink
glycosyl
site
orf
v
g
midwv
orf
v
predict
six
nlink
glycosyl
site
orf
v
g
mihindukulasuriya
et
al
soybean
cyst
nematod
sbcnv
belong
socyviru
genu
discov
plant
parasit
nematod
sbcnv
orf
iv
sequenc
one
potenti
nglycosyl
site
afonso
et
al
bekal
et
al
newest
genu
famili
consist
pteromalu
puparum
negativestrand
rna
viru
found
tissu
parasitoid
wasp
pteromalu
puparum
may
transmit
vertic
infect
wasp
orf
iv
protein
contain
seven
put
olink
four
put
nlink
glycosyl
site
wang
et
al
paramyxovirida
famili
contain
mani
veterinari
medic
import
virus
measl
viru
mev
avian
paramyxoviru
parainfluenza
virus
piv
deadli
nipah
viru
niv
hendra
viru
hev
virus
reli
coordin
effort
two
envelop
gp
enter
cell
via
viralcel
membran
fusion
event
figur
addit
paramyxovir
gpinduc
membran
fusion
requir
drop
ph
mani
viral
famili
two
gp
execut
cellcel
fusion
syncytia
event
figur
believ
pathway
viru
spread
host
cell
without
intercept
immun
system
chang
dutch
bind
attach
gp
hn
h
g
cell
surfac
receptor
trigger
fusion
gp
f
insert
host
cell
membran
facilit
viralcel
membran
fusion
iorio
et
al
chang
dutch
f
becom
biolog
activ
precursor
f
either
transport
transgolgi
network
cleav
furin
transport
cellular
surfac
subsequ
endocytos
cleav
cellular
proteas
cleav
extracellular
proteas
chang
dutch
yield
biolog
activ
gp
made
f
f
subunit
link
disulfid
bond
f
transport
surfac
plasma
membran
lamb
park
discuss
glycan
function
paramyxovir
genu
aquaparamyxoviru
avulaviru
ferlaviru
henipaviru
morbilliviru
respiroviru
rubulaviru
aquaparamyxoviru
genu
current
sole
compris
atlant
salmon
paramyxoviru
asapv
upon
infect
inflamm
gill
respiratori
distress
follow
accru
mortal
farm
atlant
salmon
kvellestad
et
al
asapv
f
two
put
nglycosyl
site
one
f
subunit
one
f
subunit
hn
protein
four
potenti
nglycosyl
site
unknown
function
falk
et
al
newcastl
diseas
viru
infect
avian
speci
endem
mani
thirdworld
countri
design
caus
sever
econom
loss
mani
poultri
farmer
due
high
morbid
mortal
infecti
natur
ganar
et
al
studi
cell
cell
line
lack
enzym
necessari
convert
highmannos
nglycan
complex
hybrid
form
suggest
fusion
infect
depend
hybrid
complex
nglycan
suggest
highmannos
nglycan
may
play
role
cellcel
fusion
howev
fold
gp
studi
contain
four
nglycosyl
site
mutat
site
alter
f
process
decreas
cellcel
fusion
mcginn
et
al
contrast
remov
nglycan
specif
heptad
repeat
region
combin
result
increas
virul
immunogen
virion
samal
et
al
suggest
effect
nglycan
may
locationspecif
interestingli
latter
studi
also
found
remov
nglycan
affect
process
cse
conflict
previous
mention
studi
differ
may
due
use
transfect
vs
infect
cell
use
st
mutat
first
studi
vs
n
q
mutat
second
hn
util
four
six
potenti
nglycosyl
site
two
modul
protein
fold
activ
mcginn
morrison
n
q
mutat
caus
alter
fusion
activ
usual
lower
one
doubl
mutant
increas
fusogen
less
virul
panda
et
al
interest
result
sinc
fusogen
often
directli
correl
virul
mutant
lower
cse
suggest
ctermin
nglycan
import
process
andor
transport
none
mutant
alter
cell
receptorbind
abil
though
two
decreas
neuraminidas
activ
suggest
decreas
virul
mutant
may
due
least
partial
decreas
cellular
detach
abil
panda
et
al
furthermor
shown
failur
form
disulfid
bond
result
addit
nglycosyl
possibl
caus
differenti
fold
expos
otherwis
obscur
site
glycosyltransferas
mcginn
morrison
howev
mutat
introduc
nglycan
effect
neutral
antibodi
reduc
interestingli
mutat
also
reduc
fusion
within
fusion
induc
infect
cell
increas
fusion
without
cellcel
fusion
mediat
viru
high
multipl
infect
overal
addit
nglycan
caus
diminish
syncytium
format
compar
wildtyp
hn
enabl
viru
escap
neutral
mab
specif
antigen
site
deng
et
al
effect
addit
glycosyl
virul
pathogen
howev
still
somewhat
unclear
ferdel
viru
fdlv
isol
outbreak
swiss
serpentarium
caus
lethargi
respiratori
distress
death
clark
et
al
fdlv
may
caus
epidem
captiv
reptil
popul
high
mortal
rate
folsch
leloup
fdlv
hn
gp
two
put
nlink
glycosyl
site
fdlv
f
gp
three
put
nlink
glycosyl
site
two
within
f
subunit
one
f
kurath
et
al
studi
role
glycan
viru
life
cycl
conduct
henipaviru
genu
contain
deadli
emerg
zoonot
niv
hev
well
cedar
mojiang
kumasi
dozen
new
uncharacter
unnam
henipavirus
recent
discov
bat
drexler
et
al
marsh
wang
wu
et
al
glycobiolog
studi
far
focus
niv
hev
infect
niv
hev
result
sever
respiratori
neurolog
symptom
human
progress
fatal
enceph
case
lubi
et
al
virus
biosafeti
level
pathogen
current
approv
treatment
vaccin
avail
human
use
niv
f
glycosyl
four
five
potenti
nglycosyl
site
moll
et
al
aguilar
et
al
loss
nglycan
n
q
mutat
result
increas
fusogen
also
increas
suscept
antibodi
neutral
impli
need
niv
balanc
two
import
glycan
function
one
nglycan
rel
import
protein
expressiontransport
aguilar
et
al
nglycosyl
site
use
hev
f
similarli
equival
nglycan
niv
hev
import
proper
fold
transport
remov
nglycan
yield
increas
fusion
two
signific
effect
fusion
carter
garner
et
al
garner
et
al
levroney
et
al
demonstr
import
time
viral
exposur
innat
immun
factor
six
seven
potenti
niv
g
nglycosyl
site
util
one
stalk
five
globular
head
domain
remov
nglycan
head
region
niv
g
gener
result
increas
fusion
synergist
effect
observ
doubl
tripl
mutant
higher
fusion
level
individu
site
counterpart
mutant
also
suscept
antibodi
neutral
similar
niv
f
nglycan
contrast
remov
nglycan
niv
g
stalk
creat
fusiondead
mutant
even
combin
remov
nglycan
site
creat
hyperfusogen
mutant
remov
niv
g
nglycan
remov
also
affect
viral
entri
bind
avid
niv
f
though
protein
conform
receptorbind
capabl
significantli
affect
bier
et
al
remov
nglycan
hev
g
reveal
similar
trend
howev
simultan
remov
multipl
nglycan
hev
result
much
stronger
reduct
cse
niv
addit
remov
nglycan
hev
g
result
higher
cellcel
fusion
level
niv
remov
nglycan
niv
caus
higher
fusion
level
hev
bradeltretheway
et
al
differ
suggest
conform
function
differ
nglycan
two
close
relat
virus
andor
differ
glycan
branchingcomposit
mass
spectrometri
analysi
solubl
hev
g
show
contain
mainli
complex
nglycan
colgrav
et
al
similar
mass
spectrometri
analysi
perform
niv
g
interestingli
loss
nglycan
niv
hev
correl
enhanc
membran
fusion
also
looser
fg
gpgp
interact
phenotyp
illustr
inher
fusogen
capac
gp
also
interact
import
membran
fusion
function
modul
nglycan
result
also
help
confirm
fg
dissoci
model
membran
fusion
paramyxoviru
genu
aguilar
et
al
aguilar
iorio
bradeltretheway
et
al
rel
littl
known
function
oglycan
mononegaviral
function
describ
paramyxovir
oglycan
recent
studi
stone
et
al
hev
g
shown
contain
oglycan
via
mass
spectrometri
colgrav
et
al
loss
specif
oglycosyl
site
hev
g
stalk
affect
cellcel
fusion
protein
conform
chang
bind
avid
hev
f
pseudotyp
viral
entri
quit
interestingli
hev
f
protein
process
incorpor
pseudotyp
virion
stone
et
al
sinc
f
g
thought
interact
reach
cell
surfac
quit
interest
loss
oglycan
g
affect
f
incorpor
virion
especi
sinc
effect
observ
pseudotyp
virion
cell
lysat
similar
effect
observ
oglycan
mutant
niv
g
except
interestingli
niv
f
incorpor
pseudotyp
virion
pseudotyp
viral
entri
alter
loss
oglycan
niv
g
addit
one
mutant
niv
g
unabl
express
cell
surfac
even
though
hev
g
counterpart
express
wildtyp
g
level
stone
et
al
loss
oglycan
either
hev
niv
g
effect
antibodi
neutral
suscept
demonstr
function
differ
nand
oglycan
henipavirus
addit
oglycan
shown
affect
g
oligomer
result
suggest
import
nand
oglycan
henipaviru
life
cycl
though
appear
subtl
differ
effect
niv
hev
morbilliviru
genu
contain
import
virus
mev
canin
distemp
viru
cdv
measl
infect
repres
one
largest
caus
childhood
morbid
mortal
addit
acut
infect
character
develop
skin
rash
risk
develop
subacut
scleros
panenceph
often
fatal
neurolog
diseas
result
persist
mev
infect
griffin
et
al
cdv
caus
symptom
fever
respiratori
distress
neurolog
disord
infect
dog
mani
carnivor
speci
harder
osterhau
martella
et
al
nglycan
mev
f
mev
h
import
syncytia
format
malvoisin
wild
specif
process
nglycan
crucial
treatment
inhibitor
castanospermin
reveal
trim
glucos
residu
within
er
requir
syncytia
format
infect
malvoisin
wild
bolt
et
al
addit
tunicamycin
treatment
block
nglycan
synthesi
inhibit
virion
particl
format
stallcup
field
three
potenti
mev
f
nglycosyl
site
glycosyl
nglycan
remov
result
loss
protein
cse
andor
process
alkhatib
et
al
von
messl
cattaneo
nonconserv
mutat
n
andor
result
lack
mev
f
process
transport
cell
surfac
hu
et
al
result
similar
conserv
mutat
n
q
nglycan
loss
result
reduc
mev
f
cse
alkhatib
et
al
interestingli
mutant
still
fusion
activ
mutant
find
differ
n
mutat
neither
mutant
fusogen
suggest
loss
fusion
mutant
due
loss
n
residu
glycan
mutat
alon
affect
protein
process
fusogen
combin
loss
either
two
glycan
result
impair
cleavag
stabil
cse
process
fusion
alkhatib
et
al
result
highlight
import
partial
flexibl
nglycan
mev
f
proper
protein
process
express
function
mev
h
glycosyl
four
five
potenti
nglycosyl
site
bolt
et
al
two
four
nglycan
affect
gp
conform
measur
conform
mab
individu
nglycan
affect
fold
oligomer
transport
presenc
least
two
four
nglycan
necessari
function
suggest
transport
fold
depend
specif
carbohydr
chain
reli
collect
carbohydr
function
hu
et
al
crystal
data
suggest
nglycan
may
modul
receptor
bind
posit
mev
h
receptor
bind
hashiguchi
et
al
support
notion
mev
h
bind
receptor
shown
depend
nglycan
oglycan
mev
h
suggest
nglycan
help
keep
mev
h
conform
recogn
likewis
receptor
also
requir
nglycan
serv
receptor
mev
h
maisner
et
al
maisner
et
al
maisner
herrler
howev
argu
relev
vivo
receptor
noyc
richardson
thu
biolog
signific
find
remain
determin
effect
glycosyl
mev
h
interact
signal
lymphocyt
activ
molecul
slam
nectin
two
known
biolog
relev
receptor
mev
report
regardless
nglycan
mev
h
appear
play
gener
role
keep
mev
h
favor
function
conform
similar
mev
f
n
q
mutat
demonstr
cdv
f
also
use
three
potenti
nglycosyl
site
nglycan
import
process
protein
stabil
cse
fusion
von
messl
cattaneo
cdv
h
contain
three
nglycosyl
site
conserv
among
cdv
strain
addit
five
site
present
wildtyp
strain
loss
nglycosyl
site
cdv
h
use
n
q
mutat
result
function
immunosuppress
cdv
h
gp
one
longer
caus
diseas
sawatski
von
messl
also
suggest
lack
nglycan
attenu
vaccin
strain
may
respons
loss
virul
iwatsuki
et
al
result
support
import
nglycan
gp
function
pathogen
vaccin
develop
notabl
nglycan
presenc
appear
conserv
morbilliviru
f
gp
three
three
site
mev
cdv
conserv
posit
h
gp
four
five
mev
eight
cdv
suggest
h
higher
host
immun
pressur
human
parainfluenza
viru
hpiv
type
major
caus
respiratori
tract
infect
children
elderli
immunocompromis
individu
mishin
et
al
chu
et
al
bailli
et
al
sendai
viru
sev
murin
viru
function
model
viru
mani
paramyxovir
studi
pfaller
et
al
hn
gp
util
three
four
potenti
nglycosyl
site
mutat
n
site
reveal
nglycan
hn
import
receptor
bind
f
cleavag
fusion
hn
avid
neuraminidas
activ
chu
et
al
remark
nglycan
loss
hn
affect
f
cleavag
without
affect
overal
interact
find
warrant
investig
suggest
role
unknown
factor
involv
addit
nglycan
hn
found
cover
second
receptorbind
site
mishin
et
al
similar
observ
seen
hn
residu
alymova
et
al
though
implic
addit
bind
site
viral
infect
yet
defin
similar
sev
hn
util
three
four
potenti
nglycosyl
site
mass
attribut
glycan
modif
kohama
et
al
segawa
et
al
nglycan
play
signific
role
intracellular
transport
fusion
segawa
et
al
fifteen
percent
mass
sev
f
attribut
oglycan
modif
kohama
et
al
sev
f
three
nglycosyl
site
remov
site
affect
protein
fold
traffick
cse
result
fusion
segawa
et
al
highmannos
sugar
thought
necessari
immunoreact
sev
f
sev
hn
mottet
et
al
addit
tunicamycin
treatment
inhibit
sev
viral
replic
nakamura
et
al
thu
clear
nglycan
play
signific
role
protein
process
proper
viral
function
virus
target
glycan
may
potenti
therapeut
option
parainfluenza
viru
broad
host
rang
includ
cat
dog
pig
guinea
pig
hamster
piv
caus
hospit
human
chatziandr
et
al
f
util
six
potenti
nglycosyl
site
remov
two
f
subunit
nglycan
via
n
mutat
signific
effect
howev
remov
four
f
subunit
nglycan
result
protein
degrad
instabl
delay
intracellular
transport
cse
fusion
bagai
lamb
hn
contain
four
nglycan
affect
protein
fold
assembl
cumul
manner
addit
one
four
nglycan
prevent
aggreg
oligom
er
ng
et
al
thu
nglycan
f
hn
play
role
proper
protein
fold
thu
facilit
proper
viral
protein
function
mump
viru
muv
caus
pain
swell
salivari
gland
well
potenti
system
inflamm
organ
includ
brain
heart
kidney
though
rare
fatal
case
infect
result
longterm
symptom
paralysi
seizur
deaf
introduct
vaccin
mump
common
childhood
infect
rubin
et
al
tunicamycin
treatment
inhibit
viral
releas
like
trap
viral
gp
cytoplasm
infect
cell
hn
f
gp
nglycosyl
complex
highmannos
glycan
hn
f
subunit
high
mannos
f
subunit
reveal
endoglycosidas
treatment
herrler
compan
muv
f
contain
six
potenti
nglycosyl
site
alirezai
et
al
muv
hn
contain
five
seven
potenti
nglycosyl
site
lim
et
al
yate
et
al
though
site
util
function
remain
unknown
thu
unknown
whether
nglycan
function
among
rubulavirus
conserv
paramyxovirus
vari
extens
host
rang
distribut
share
mani
similar
within
gp
f
hnhg
gp
viru
within
famili
contain
number
nglycan
though
number
nglycosyl
site
util
vari
wide
among
genera
nglycan
commonli
appear
role
protein
express
process
traffick
cell
surfac
cellcel
fusion
product
infecti
virion
addit
mani
nglycan
also
affect
pathogen
immunogen
glycan
hn
affect
receptor
bind
other
effect
receptor
bind
affect
cellular
detach
addit
oglycan
detect
paramyxovir
gp
function
far
determin
niv
hev
g
gp
research
determin
oglycan
function
conserv
among
paramyxovir
genera
orthopneumoviru
human
respiratori
syncyti
viru
hrsv
also
refer
rsv
caus
sever
bronchiol
infant
account
childhood
bronchiol
case
requir
hospit
rodriguez
ramilo
estim
children
least
one
hrsv
infect
age
borcher
et
al
interestingli
hrsv
fusion
gp
requir
cellcel
fusion
viral
entri
occur
though
presenc
hrsv
g
enhanc
fusion
chang
dutch
hrsv
infect
sensit
oglycan
remov
lambert
hrsv
f
util
three
six
potenti
nglycosyl
site
remov
nglycan
conserv
n
q
mutat
affect
hrsv
f
express
process
cleavag
activ
howev
one
mutant
increas
fusion
anoth
mutant
fusion
reduct
mutant
lack
three
nglycosyl
site
almost
fusion
zimmer
et
al
sinc
conform
protein
test
possibl
alter
fusion
phenotyp
due
alter
protein
conform
conform
mab
may
help
determin
case
importantli
still
unknown
whether
hrsv
f
glycan
affect
bind
hrsv
f
palivizumab
therapeut
mab
hrsv
knowledg
still
mab
approv
use
human
viru
hrsv
g
shown
heavili
oglycosyl
mass
nglycan
oglycan
base
gel
motil
lambert
interestingli
certain
mab
bind
nonglycosyl
g
palomo
et
al
recognit
mab
depend
cellspecif
glycosyl
garciabeato
et
al
oglycan
shown
involv
hrsv
g
oligomer
collin
mottet
addit
model
studi
suggest
posit
select
certain
oglycan
respons
immun
pressur
zlateva
et
al
suggest
viral
glycosyl
may
play
import
role
host
immun
respons
studi
immun
respons
glycosyl
may
lead
effect
vaccin
therapeut
option
hrsv
human
metapneumoviru
hmpv
caus
sever
upper
lower
respiratori
tract
infect
account
childhood
acut
respiratori
infect
hospit
panda
et
al
infect
gener
occur
childhood
recurr
throughout
life
addit
infect
children
hmpv
also
pose
threat
immunocompromis
individu
includ
elderli
panda
et
al
hmpv
f
util
three
potenti
nglycosyl
site
one
f
two
f
subunit
n
mutat
result
decreas
cellcel
fusion
like
caus
reduc
f
cleavag
mutant
express
well
cell
surfac
schowalt
et
al
anoth
studi
mutant
lack
ctermin
nglycan
either
alon
combin
remov
nglycosyl
site
produc
virion
zhang
et
al
although
n
q
vs
n
mutat
well
viru
vs
transfect
cell
signific
differ
two
studi
appear
nglycan
hmpv
f
affect
cleavag
f
f
f
subunit
impact
viral
replic
cellcel
fusion
schowalt
et
al
zhang
et
al
virus
lack
glycan
display
impair
growth
vitro
vivo
reduc
patholog
immunocompet
immunocompromis
mice
zhang
et
al
yu
et
al
administr
live
vaccin
attenu
loss
glycan
result
immun
protect
mice
liu
et
al
highlight
way
knowledg
viral
glycosyl
aid
viral
infect
prevent
strategi
like
hrsv
g
hmpv
g
heavili
glycosyl
three
six
potenti
nglycosyl
site
depend
strain
unknown
number
oglycan
bastien
et
al
galiano
et
al
liu
et
al
sequenc
hmpv
g
strain
howev
reveal
high
serin
threonin
content
suggest
hmpv
g
may
high
oglycan
content
liu
et
al
effect
actual
put
oglycan
still
larg
undetermin
member
famili
observ
undergo
attach
proteinindepend
membran
fusion
iorio
et
al
smith
et
al
extens
olink
well
nlink
glycosyl
g
gp
along
high
prolin
content
suggest
g
gp
mucinlik
structur
johnson
et
al
langedijk
et
al
though
function
pneumovirida
fusion
gp
nglycan
character
purpos
g
gp
nand
oglycan
remain
unknown
wide
distribut
rhabdovirus
infect
invertebr
vertebr
well
wide
varieti
plant
divid
genera
four
genera
infect
mammal
lyssaviru
contain
rabi
viru
rabv
tibroviru
vesiculoviru
contain
vsv
ephemeroviru
contain
bovin
ephemer
fever
viru
befv
tupaviru
infect
bird
da
poian
et
al
calish
ellison
three
genera
infect
fish
includ
novirhabdovirus
perhabdovirus
sprivivirus
cytorhabdovirus
nucleorhabdovirus
dichorhavirus
varicosavirus
infect
plant
falzarano
et
al
member
almendraviru
sigmaviru
ledanteviru
peropuviru
hapaviru
genera
circul
within
arthropod
popul
contamin
blasdel
et
al
contrera
et
al
wang
et
al
virus
bulletshap
morpholog
enter
cell
receptormedi
endocytosi
follow
membran
fusion
induc
low
ph
host
cell
receptor
bind
membran
fusion
execut
envelop
gp
g
two
wide
studi
virus
famili
rabv
vsv
contain
two
nglycosyl
site
jayakar
et
al
da
poian
et
al
member
almendraviru
genu
isol
mosquito
found
effect
replic
mosquito
cell
contrera
et
al
arboretum
viru
abtv
puerto
almendra
viru
ptamv
suggest
six
put
nglycosyl
site
within
g
orf
ectodomain
balsa
viru
balv
rio
chico
viru
rchv
two
put
nglycosyl
site
coot
bay
viru
cbv
contain
five
contrera
et
al
role
put
nglycan
determin
member
curioviru
genu
report
lethal
mice
caus
necrosi
pyknosi
curionopoli
ibiriu
itacainu
virus
isol
brazil
speci
culicoid
insect
caus
neuropathogenesi
mice
gomesl
et
al
diniz
et
al
character
curioviru
gp
conduct
plant
rhabdovirus
separ
cytorhabdoviru
nucleorhabdoviru
genera
depend
site
replic
morphogenesi
jackson
et
al
number
potenti
nglycosyl
site
virus
vari
wide
cytorhabdoviru
lettuc
necrot
yellow
viru
lnyv
g
contain
three
potenti
nglycosyl
site
northern
cereal
mosaic
viru
ncmv
contain
six
goldberg
et
al
tanno
et
al
jackson
et
al
dietzgen
et
al
nucleorhabdovirus
rice
yellow
stunt
viru
rysv
sonchu
yellow
net
viru
synv
contain
potenti
nglycosyl
site
respect
jackson
et
al
tunicamycin
treatment
suggest
least
nglycosyl
site
use
jackson
et
al
interestingli
littl
sequenc
homolog
ncmv
synv
g
yet
potenti
glycosyl
similar
site
suggest
import
glycosyl
site
conserv
tanno
et
al
function
nglycan
howev
yet
determin
dichoravirus
includ
coffe
ringspot
viru
corsv
orchid
fleck
viru
ofv
synonym
citru
leprosi
viru
nuclear
type
citru
necrot
spot
viru
caus
necrot
symptom
plant
speci
spread
brevipalpu
speci
mite
ofv
g
protein
two
potenti
nglycosyl
site
interestingli
propos
fewer
potenti
nglycan
may
contribut
incomplet
bud
process
virion
kondo
et
al
kondo
et
al
befv
infect
occur
mainli
cattl
buffalo
africa
asia
australia
caus
acut
fever
lame
result
high
morbid
econom
loss
befv
also
infect
rumin
without
caus
diseas
nandi
negi
befv
g
contain
five
potenti
nglycosyl
site
addit
nonstructur
protein
similar
g
term
g
ns
contain
eight
potenti
nglycosyl
site
johal
et
al
g
ns
detect
within
infect
cell
howev
found
virion
appear
induc
immun
respons
util
potenti
nglycosyl
site
glycan
function
still
unknown
walker
et
al
johal
et
al
sever
virus
new
genu
infect
mammal
bird
insect
reptil
though
isol
mosquito
causey
et
al
karabatso
simo
tchetgna
et
al
ngaingan
viru
ngav
first
isol
bite
midg
australia
predict
four
nglycosyl
site
ngav
g
doherti
et
al
gubala
et
al
marco
viru
isol
lizard
brazil
two
put
nlink
glycosyl
site
transmembran
gp
causey
et
al
walker
et
al
glycan
function
studi
hapaviru
speci
within
ledanteviru
genu
kolent
viru
four
put
nglycosyl
site
unexplor
function
within
gp
lyssaviru
rabv
infect
mammal
transmit
bite
scratch
saliva
infect
character
neurolog
symptom
culmin
sever
enceph
fatal
human
untreat
calish
ellison
rabv
g
usual
contain
one
nglycosyl
site
highli
conserv
among
differ
rabv
strain
wunner
et
al
wunner
et
al
badran
tordo
yamada
et
al
addit
nglycan
site
found
mani
labadapt
strain
wunner
et
al
suggest
latter
nglycan
may
play
role
reduc
pathogen
observ
mani
labadapt
strain
possibl
increas
effici
growth
cell
cultur
yamada
et
al
yamada
et
al
ineffici
glycosyl
effort
increas
nglycosyl
effici
reduc
pathogen
viru
wunner
et
al
shakineshleman
et
al
yamada
et
al
loss
nglycan
result
decreas
viral
product
inabl
rabv
g
fold
correctli
inhibit
membran
fusion
yamada
et
al
delet
three
nglycan
complet
block
cse
mutant
contain
glycan
still
abl
express
cell
surfac
suggest
ineffici
glycosyl
site
import
cse
shakineshleman
et
al
addit
extra
nglycan
creat
spontan
mutat
serial
passag
increas
viru
product
yamada
et
al
thu
appear
nglycan
play
crucial
role
proper
rabv
g
cse
though
combin
effect
glycan
nglycan
site
suggest
crucial
balanc
mani
nglycan
neg
impact
viral
pathogen
tunicamycin
treatment
block
cse
rabv
g
intracellular
synthesi
burger
et
al
wojczyk
et
al
addit
experi
panel
variou
cho
cell
line
defici
differ
step
nglycan
process
pathway
reveal
rabv
g
express
independ
type
nglycan
process
cell
line
express
rabv
g
cell
surfac
burger
et
al
still
possibl
rabv
g
traffick
differ
rate
time
rabv
g
cse
explor
notabl
mutat
site
facilit
addit
glycosyl
site
wojczyk
et
al
recombin
rabv
g
protein
produc
eukaryot
cell
thu
glycosyl
effect
vaccin
wiktor
et
al
rabv
g
protein
produc
prokaryot
cell
thu
glycosyl
effect
yelverton
et
al
differ
could
due
factor
protein
conform
possibl
proper
glycosyl
rabv
g
necessari
effect
immun
respons
howev
anoth
studi
indic
glycan
may
requir
target
mous
antibodi
wunner
et
al
suggest
immunoreact
rabv
g
multifactori
undoubtedli
nglycan
play
critic
role
least
proper
cse
rabv
g
though
effect
host
immun
respons
merit
explor
virus
within
novirhabdoviru
genu
infect
fish
speci
caus
signific
morbid
mortal
virus
includ
infecti
hematopoiet
necrosi
viru
ihnv
hiram
rhabdoviru
hirv
viral
hemorrhag
septicemia
viru
vhsv
among
other
caus
vast
aquacultur
wildlif
problem
purcel
et
al
though
number
potenti
nglycan
vari
viru
put
nglycan
posit
present
viru
analyz
lorenzen
et
al
bjorklund
et
al
ihnv
g
contain
four
potenti
nglycosyl
site
one
potenti
oglycosyl
site
ammayappan
et
al
vhsv
also
contain
four
potenti
nglycosyl
site
chico
et
al
ihnv
vhsv
share
similar
glycosyl
pattern
one
put
nglycan
nterminu
none
middl
protein
three
cterminu
lorenzen
et
al
hirv
contain
three
put
nglycosyl
sitesal
cterminu
bjorklund
et
al
studi
function
glycan
howev
yet
undertaken
perhabdovirus
associ
fish
infect
eel
viru
european
x
evex
major
concern
farm
freshwat
eel
anguilla
speci
increas
mortal
symptom
includ
hemorrhag
skin
lesion
caruso
et
al
evex
g
protein
one
nglycosyl
site
galini
et
al
function
glycan
genu
remain
unknown
five
member
drosophila
genu
one
member
muscida
natur
host
sigma
virus
caus
paralysi
death
upon
exposur
carbon
dioxid
sigma
virus
vertic
mode
transmiss
gamet
male
femal
fli
drosophila
melanogast
sigmaviru
dmelsv
surfac
gp
g
longdon
et
al
longdon
et
al
much
known
regard
number
function
glycan
genu
virus
within
spriviviru
genu
infect
fish
speci
caus
signific
morbid
mortal
purcel
et
al
virus
includ
spring
viremia
carp
viru
svcv
pike
fri
rhabdoviru
pfrv
much
known
glycosyl
virus
except
svcv
g
gp
contain
five
potenti
nglycosyl
site
variat
glycosyl
site
due
nucleotid
insert
differ
svcv
strain
bjorklund
et
al
zhang
et
al
potenti
function
glycan
virus
yet
studi
within
sripuviru
genu
almpiwar
viru
g
gp
contain
two
possibl
glycosyl
site
unknown
biolog
function
mcallist
et
al
sandfli
niakha
viru
g
gp
report
possess
two
potenti
nglycosyl
site
vasilaki
et
al
tibroviru
transmit
culicoid
insect
infect
member
bovin
speci
tibrovirus
observ
induc
ill
tibrogargan
viru
tibv
coastal
plain
viru
cpv
g
protein
predict
contain
nine
nglycosyl
site
cybinski
et
al
gubala
et
al
account
made
function
glycosyl
site
genu
tupaia
viru
tupv
first
isol
liver
tumor
tupaia
tree
shrew
tupaia
belangeri
kurz
et
al
tupv
g
protein
possess
three
potenti
nglycosyl
site
springfeld
et
al
durham
viru
durv
first
isol
american
coot
suffer
neurolog
symptom
durv
g
protein
report
two
possibl
nglycosyl
site
allison
et
al
much
known
regard
number
function
glycan
genu
sole
member
varicosaviru
genu
lettuc
bigveinassoci
viru
lbvav
lbvav
caus
pale
yellow
vein
leav
lettuc
character
leaf
pucker
consid
soilborn
transmit
zoospor
fungu
olpidium
brassica
healthi
lettuc
plant
contamin
soil
develop
sign
infect
tomlinson
et
al
umar
et
al
lbvav
difficult
mechan
transmiss
make
studi
problemat
sasaya
et
al
report
glycobiolog
genu
vesiculoviru
vsv
infect
mainli
livestock
caus
sever
blister
andor
ulcer
tongu
mouth
feet
often
result
extens
product
loss
letchworth
et
al
vsv
also
use
extens
product
pseudotyp
virus
due
abil
incorpor
viral
gp
mani
viral
famili
huang
et
al
witt
baltimor
vsv
gp
g
contain
two
wellconserv
nglycosyl
site
make
approxim
gp
mass
oglycosyl
site
discov
holland
robertson
et
al
read
et
al
farley
et
al
tunicamycin
treatment
particularli
san
juan
strain
impair
intracellular
transport
vsv
g
plasma
membran
leavitt
et
al
morrison
et
al
gibson
et
al
inhibit
viral
replic
leavitt
et
al
alter
mabbind
pattern
vsv
g
gp
grigera
et
al
howev
effect
appear
partial
strainspecif
tunicamycin
treatment
new
jersey
strain
slow
fold
rate
vsv
g
prevent
eventu
express
cell
surfac
mathieu
et
al
addit
orsay
strain
show
resist
tunicamycin
treatment
gibson
et
al
appear
observ
effect
reliant
presenc
glycan
specif
type
carbohydr
ad
import
exampl
vsv
particl
produc
varieti
cho
cell
lack
specif
step
glycosyl
pathway
still
abl
replic
infecti
fulli
glycosyl
counterpart
schlesing
et
al
robertson
et
al
also
shown
either
two
nglycan
necessari
suffici
proper
g
transport
macham
et
al
observ
support
natur
occur
mutant
contain
one
nglycan
traffick
properli
cell
surfac
kotwal
et
al
also
observ
addit
new
nglycosyl
site
unglycosyl
vsv
g
allow
transport
g
plasma
membran
though
restor
transport
abil
success
two
six
engin
nglycosyl
site
macham
rose
find
experi
temperaturesensit
mutant
led
hypothesi
nglycan
vsv
g
import
proper
fold
conform
chati
morrison
macham
rose
perhap
affect
stabil
disulfid
bond
grigera
et
al
alter
conform
absenc
nglycosyl
site
result
lack
transport
cell
surfac
chati
morrison
macham
rose
observ
low
amount
infecti
viru
produc
even
presenc
tunicamycin
possibl
glycan
mutant
virion
differ
conform
may
thu
abl
traffic
cell
surfac
despit
lack
glycosyl
gibson
et
al
may
also
explain
certain
strain
resist
tunicamycin
treatment
other
differ
amino
acid
sequenc
may
result
differ
conform
less
reliant
nglycan
structur
integr
chati
morrison
thu
appear
either
two
natur
nglycan
necessari
suffici
proper
vsv
g
transport
express
suggest
proper
gp
conform
specif
nglycan
import
vsv
g
express
function
lyssaviru
vesiculoviru
genera
two
highli
conserv
nglycan
g
suggest
site
evolutionarili
import
inde
sequenc
comparison
rabv
g
vsv
g
show
approxim
overal
sequenc
ident
two
gp
yet
greater
ident
around
ctermin
nglycosyl
site
exact
align
nglycosyl
site
rose
et
al
genera
nglycan
appear
necessari
proper
transport
cell
surfac
one
nglycan
suffici
cell
transport
function
macham
et
al
kotwal
et
al
shakineshleman
et
al
addit
depend
nglycan
proper
traffick
independ
type
glycan
process
evidenc
varieti
glycosylationdefici
cho
cell
g
gp
still
express
cell
surfac
burger
et
al
schlesing
et
al
robertson
et
al
effect
nglycan
appear
strainspecif
vsv
although
rabv
strain
differ
number
nglycan
present
effect
tunicamycin
treatment
appear
variabl
among
vsv
strain
among
rabv
strain
gener
comparison
among
rhabdovirus
difficult
make
sinc
far
fewer
studi
exist
howev
virus
could
potenti
contain
nglycosyl
site
lyssaviru
vesiculoviru
counterpart
though
studi
determin
site
usag
yet
undertaken
sunvirida
famili
sole
compris
sunshin
coast
viru
sunshineviru
genu
viru
initi
isol
australian
python
snake
popul
show
symptom
neurorespiratori
diseas
known
caus
ill
human
hyndman
et
al
studi
perform
function
glycan
viru
glycosyl
common
protein
modif
process
util
anim
plant
bacteria
fungi
virus
even
archaea
illustr
import
recent
year
mani
human
ill
autoimmun
diseas
cancer
link
alter
glycosyl
varki
kannagi
et
al
glycosyl
commonli
use
pathogen
host
invas
immun
evas
within
mononegaviral
order
mani
conserv
function
glycosyl
receptor
bind
viral
entri
protein
process
traffick
cellcel
fusion
immunogen
tabl
figur
import
role
viral
life
cycl
note
much
discov
nglycan
oglycan
partli
due
difficulti
determin
oglycosyl
site
compar
nglycosyl
site
oglycan
function
describ
mani
function
attribut
oglycanrich
region
ebola
gp
yet
function
yet
directli
attribut
oglycan
new
studi
henipaviru
genu
novel
role
shown
niv
hev
oglycan
stone
et
al
remain
seen
role
appli
paramyxovirus
mononegavirus
thorough
understand
viral
glycosyl
potenti
therapeut
use
glycomimet
compound
mimic
bioactiv
properti
carbohydr
develop
test
number
differ
viral
infect
magnani
ernst
glucosemimet
dnj
exampl
inhibit
part
glycosyl
pathway
thu
prevent
viral
gp
fold
properli
francoi
balzarini
dalziel
et
al
dnj
shown
effect
combat
hiv
hepat
b
c
virus
suggest
possibl
therapeut
flavivirus
dengu
viru
west
nile
viru
merri
astrautsova
carbohydr
mimet
suggest
good
drug
candid
gener
low
toxic
water
solubl
easili
modifi
ad
differ
function
group
multipl
locat
potenti
use
scaffold
complex
drug
merri
astrautsova
howev
carbohydr
gener
thought
make
poor
drug
candid
due
high
polar
prevent
passiv
transport
intestin
line
thu
problemat
oral
dose
regimen
use
carbohydr
mimet
enabl
suffici
manipul
overcom
barrier
addit
glycan
protein
also
use
tool
studi
protein
function
exampl
paramyxovir
hnh
g
attach
gp
nglycan
ad
studi
effect
protein
stalk
membran
fusion
interact
fusion
protein
done
ndv
niv
probe
protein
function
melanson
iorio
bose
et
al
zhu
et
al
lectin
carbohydratebind
agent
also
investig
antivir
therapi
cyanovirin
lectin
bind
gp
hiv
prevent
entri
test
mani
virus
well
merri
astrautsova
francoi
balzarini
carbohydratebind
agent
bind
viral
gp
prevent
entri
also
creat
longterm
select
pressur
viral
strain
protect
nglycan
region
remov
thu
make
viru
suscept
immun
system
neutral
francoi
balzarini
lectin
also
found
natur
across
wide
varieti
speci
prokaryot
alga
fungi
plant
invertebr
vertebr
thu
mani
differ
lectin
explor
potenti
viral
inhibitor
francoi
balzarini
antibodi
carbohydr
viral
protein
though
less
common
also
effect
antibodi
bind
nglycan
region
hiv
thu
inhibit
viral
entri
host
cell
limit
hiv
infect
merri
astrautsova
francoi
balzarini
thu
number
viral
glycosylationtarget
therapeut
develop
potenti
inhibit
viral
infect
also
like
combin
strategi
prove
best
maxim
therapeut
benefit
signific
advanc
understand
character
viral
glycosyl
made
still
mani
knowledg
gap
mass
spectrometr
data
mani
viral
gp
still
nonexist
particularli
oglycan
method
commonli
use
studi
glycosyl
effect
tunicamycin
treatment
may
caus
addit
cellular
effect
thu
effect
observ
tunicamycin
treatment
may
treatment
directli
lack
glycosyl
signific
hurdl
overcom
consider
variat
glycosyl
machineri
among
differ
cell
type
therefor
effect
glycosyl
observ
one
studi
may
hold
true
cell
type
vivo
nevertheless
advanc
made
recent
year
knowledg
gain
continu
highlight
crucial
proper
glycosyl
viral
gp
function
viral
pathogen
improv
understand
viral
glycosyl
essenti
pave
way
futur
therapeut
vaccin
target
import
medic
agricultur
veterinari
virus
work
support
nation
institut
health
hac
ja
emc
vo
none
declar
